Referenced link: https://medicalxpress.com/news/2023-06-hints-cancer-immunotherapy-safer.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-06-hints-cancer-immunotherapy-safer.html

Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1671540746506104834#m

RT by @physorg_com: Study hints at how ##cancerimmunotherapy can be safer @yale @nature https://medicalxpress.com/news/2023-06-hints-cancer-immunotherapy-safer.html

Referenced link: https://medicalxpress.com/news/2023-05-tool-cancer-immunotherapy.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-05-tool-cancer-immunotherapy.html

Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1658852139538456579#m

RT by @physorg_com: New computational tool identifies novel targets for ##cancerimmunotherapy @PNASNews https://pnas.org/doi/10.1073/pnas.2221116120 https://medicalxpress.com/news/2023-05-tool-cancer-immunotherapy.html

Referenced link: https://medicalxpress.com/news/2023-05-gut-boost-cancer-immunotherapy-power.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-05-gut-boost-cancer-immunotherapy-power.html

Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1653776439097929733#m

RT by @physorg_com: Researchers look to the gut to boost ##cancerimmunotherapy's fighting power @harvardmed @nature https://medicalxpress.com/news/2023-05-gut-boost-cancer-immunotherapy-power.html

#CancerImmunotherapy @Nature Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
https://www.nature.com/articles/s41577-023-00867-9.pdf

Referenced link: https://medicalxpress.com/news/2023-03-lymph-nodes-boost-success-cancer.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-03-lymph-nodes-boost-success-cancer.html

Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1637868622344249364#m

RT by @physorg_com: Can #lymphnodes boost the success of #cancerimmunotherapy? @ucsf @CellCellPress https://linkinghub.elsevier.com/retrieve/pii/S0092867423001642 https://medicalxpress.com/news/2023-03-lymph-nodes-boost-success-cancer.html

#IDMastodon #oncologyresearch A non-#antibiotic- disrupted #gutmicrobiome is associated with clinical responses to CD19- #CARTcell #CancerImmunotherapy @NatureBiotech
@Elinav_Lab Clinical Evidences from human studies and preclinical experiments have identified the #gutmicrobiome and its effectors as potential major biological variables impacting the efficacy of #CarTcell-driven #Cancerimmunotherapies and their toxicities.
📌 https://www.nature.com/articles/s41591-023-02234-6.pdf

#oncologyresearch #Cancerbiology #CancerImmunotherapy @cellpress
Understanding the Concomitant inhibition of #PPARγ and #mTORC1 induces the differentiation of human monocytes into highly immunogenic dendritic cells.
📌 https://www.cell.com/cell-reports/fulltext/S2211-1247(23)00167-5?rss=yes&utm_source=dlvr.it&utm_medium=twitter
📌 https://www.cell.com/cell-reports/issue?pii=S2211-1247(23)X0003-5

Research Group Leader JUNIOR in Cancer Immunotherapy Research @Science_MEDMUNI

https://jobrxiv.org/job/masaryk-university-faculty-of-medicine-27778-research-group-leader-junior-in-cancer-immunotherapy-research/?feed_id=37002

#ScienceJobs #job #groupleaderjunior #cancerimmunotherapy
Brno #Czechia #GroupLeader
https://jobrxiv.org/job/masaryk-university-faculty-of-medicine-27778-research-group-leader-junior-in-cancer-immunotherapy-research/?feed_id=37002

New #cancer study from LJI's Schoenberger Lab:

"Tumor cells fail to present MHC-II restricted epitopes derived from oncogenes to CD4+ T cells" https://insight.jci.org/articles/view/165570

#OpenAccess in in LJI Insight. #immunology #ImmuneSystem #TCells #Oncology #CancerImmunotherapy #CancerResearch

Sharing our latest publication that demonstrates that mobilizing DCs to increase tumor antigen cross-presentation improves #oncolytic #virotherapy

https://rdcu.be/c1vZh

#CancerImmunotherapy

RT @SCIDirector@twitter.com

Congratulations to Stanford’s Caleb Lareau on being named a 2022 @statnews@twitter.com Wunderkind. Lareau and his mentor SCI member Ansu Satpathy study #CancerImmunotherapy. https://bit.ly/3VY8ckH @CalebLareau@twitter.com @Satpathology@twitter.com

🐦🔗: https://twitter.com/SCIDirector/status/1601275957322604545

Referenced link: https://cassyni.com/events/HdEFL124gpxCK6nLvVCevq
Discuss on https://discu.eu/q/https://cassyni.com/events/HdEFL124gpxCK6nLvVCevq

Originally posted by Nature Portfolio / @NaturePortfolio@twitter.com: https://twitter.com/SN_Oncology/status/1597893457271730177#m

RT by @NaturePortfolio: Join our Springer Nature Oncology webinar on ‘Natural Killer Cell Therapy’ today, or sign up to view the recording later if you are unable to attend the live event:
https://cassyni.com/events/HdEFL124gpxCK6nLvVCevq
#NKCellTherapy #NKCell #AdoptiveCellTherapy #CARTcelltherapy #cancerimmunotherapy

Referenced link: https://medicalxpress.com/news/2022-08-reinvigorating-lost-exhausted-cells-cancer.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2022-08-reinvigorating-lost-exhausted-cells-cancer.html

Originally posted by Phys.org / @physorg_com@twitter.com: https://twitter.com/medical_xpress/status/1555614630210306054#m

RT by @physorg_com: Reinvigorating 'lost cause' exhausted #Tcells could improve #cancerimmunotherapy @sciimmunolog https://www.science.org/doi/10.1126/sciimmunol.abj9123 https://medicalxpress.com/news/2022-08-reinvigorating-lost-exhausted-cells-cancer.html